Insider Trading History of Medicxi Growth I Gp Ltd

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Medicxi Growth I Gp Ltd since 2021. This trader's CIK number is 1715600. At the time of last reporting, Medicxi Growth I Gp Ltd was the 10% Owner of Centessa Pharmaceuticals Plc. (stock ticker symbol CNTA). Also see all insider trading activities at Centessa Pharmaceuticals Plc.

Note that in the past Medicxi Growth I GP Ltd also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Centessa Pharmaceuticals Plc (CNTA) by Medicxi Growth I Gp Ltd

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 CNTA 800,000 $14,426,662 0 $0 0 $0

Yearly summary of insider trading at Aura Biosciences, Inc. (AURA) by Medicxi Growth I Gp Ltd

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 AURA 710,000 $9,940,000 0 $0 0 $0


Insider trading activities at 2 companies by Medicxi Growth I Gp Ltd:

1. Centessa Pharmaceuticals Plc (CNTA)

2. Aura Biosciences, Inc. (AURA)

Table 1. Insider trading of Centessa Pharmaceuticals Plc (CNTA) by Medicxi Growth I Gp Ltd

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-12-02 CNTA Buy 34,326 12.82 440,059
2021-11-30 CNTA Buy 36,847 11.62 428,162
2021-12-01 CNTA Buy 60,304 12.62 761,036
2021-11-29 CNTA Buy 56,706 11.70 663,460
2021-11-26 CNTA Buy 11,817 11.34 133,945
2021-06-02 CNTA Buy 600,000 20.00 12,000,000

Table 2. Insider trading of Aura Biosciences, Inc. (AURA) by Medicxi Growth I Gp Ltd

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-11-02 AURA Buy 710,000 14.00 9,940,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Medicxi Growth I Gp Ltd (10% Owner of Centessa Pharmaceuticals Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.